91.2
Elicio Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
10.7
FY23:
16.3
FY24:
20.7
FY25:
19.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.27
FY22:
11.9
FY23:
10.8
FY24:
7.49
FY25:
6.55
Total assets
Change from FY21 to FY25
millions USD
FY21:
96.5
FY22:
22.7
FY23:
27.1
FY24:
28.2
FY25:
25.9
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.3
FY22:
6.87
FY23:
9.76
FY24:
11.5
FY25:
8.11
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.71
FY22:
6.88
FY23:
6.02
FY24:
28.0
FY25:
16.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
81.5
FY22:
−102
FY23:
11.4
FY24:
−11.3
FY25:
1.64
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
96.5
FY22:
–
FY23:
27.1
FY24:
28.2
FY25:
25.9
All amounts in millions USD